TLR4-dependent signaling drives extracellular catabolism of low-density lipoprotein aggregates

Objective Aggregation and modification of low-density lipoproteins (LDL) promotes their retention and accumulation in the arteries. This is a critical initiating factor during atherosclerosis. Macrophage catabolism of aggregated LDL (agLDL) occurs using a specialized extracellular, hydrolytic compartment, the lysosomal synapse (LS). Compartment formation by local actin polymerization and delivery of lysosomal contents by exocytosis promotes acidification of the compartment and degradation of agLDL. Internalization of metabolites such as cholesterol promotes foam cell formation, a process that drives atherogenesis. Further, there is accumulating evidence for the involvement of TLR4 and its adaptor protein MyD88 in atherosclerosis. Here, we investigated the role of TLR4 in catabolism of agLDL using the LS and foam cell formation. Approach and Results Using bone marrow-derived macrophages (BMMs) from knockout mice, we find that TLR4 and MyD88 regulate compartment formation, lysosome exocytosis, acidification of the compartment and foam cell formation. Using siRNA, pharmacological inhibition and knockout BMMs, we implicate SYK, PI3 kinase and Akt in agLDL catabolism using the LS. Using bone marrow transplantation of LDL receptor knockout mice with TLR4KO bone marrow, we show that deficiency of TLR4 protects macrophages from lipid accumulation during atherosclerosis. Finally, we demonstrate that macrophages in vivo form an extracellular compartment and exocytose lysosome contents similar to that observed in vitro for degradation of agLDL. Conclusions We present a mechanism in which interaction of macrophages with agLDL initiates a TLR4 signaling pathway, resulting in formation of the LS, catabolism of agLDL and lipid accumulation in vitro and in vivo.

[1]  F. Maxfield,et al.  Dynamic Actin Reorganization and Vav/Cdc42-Dependent Actin Polymerization Promote Macrophage Aggregated LDL (Low-Density Lipoprotein) Uptake and Catabolism , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[2]  R. Hammer,et al.  LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis , 2017, eLife.

[3]  F. Maxfield,et al.  Ceramide activation of RhoA/Rho kinase impairs actin polymerization during aggregated LDL catabolism , 2017, Journal of Lipid Research.

[4]  Frederik W. Lund,et al.  Degradation of aggregated LDL occurs in complex extracellular sub-compartments of the lysosomal synapse , 2016, Journal of Cell Science.

[5]  C. Chyau,et al.  Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells , 2016, Scientific Reports.

[6]  A. S. Haka,et al.  Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Jian Ding,et al.  PI3K isoform-selective inhibitors: next-generation targeted cancer therapies , 2015, Acta Pharmacologica Sinica.

[8]  Juan Peng,et al.  TLR4/NF-κB Signaling Contributes to Chronic Unpredictable Mild Stress-Induced Atherosclerosis in ApoE-/- Mice , 2015, PloS one.

[9]  A. Mócsai,et al.  The Phosphoinositide 3-Kinase Isoform PI3Kβ Regulates Osteoclast-Mediated Bone Resorption in Humans and Mice , 2014, Arthritis & rheumatology.

[10]  E. Dennis,et al.  Polyoxygenated Cholesterol Ester Hydroperoxide Activates TLR4 and SYK Dependent Signaling in Macrophages , 2013, PloS one.

[11]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[12]  F. Maxfield,et al.  Plasmin Promotes Foam Cell Formation by Increasing Macrophage Catabolism of Aggregated Low-Density Lipoprotein , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[13]  S. Akira,et al.  Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. , 2013, Cardiovascular research.

[14]  A. Tall,et al.  Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice , 2013, Circulation research.

[15]  Philip N. Tsichlis,et al.  Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization , 2012, Proceedings of the National Academy of Sciences.

[16]  T. Eggerman,et al.  Class B Scavenger Receptor Types I and II and CD36 Mediate Bacterial Recognition and Proinflammatory Signaling Induced by Escherichia coli, Lipopolysaccharide, and Cytosolic Chaperonin 60 , 2012, The Journal of Immunology.

[17]  F. Granucci,et al.  CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.

[18]  K. Moore,et al.  Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[19]  B. Vanhaesebroeck,et al.  The emerging mechanisms of isoform-specific PI3K signalling , 2010, Nature Reviews Molecular Cell Biology.

[20]  F. Maxfield,et al.  Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins. , 2009, Molecular biology of the cell.

[21]  F. Maxfield,et al.  Aggregated LDL in Contact With Macrophages Induces Local Increases in Free Cholesterol Levels That Regulate Local Actin Polymerization , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Andrew C. Li,et al.  Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4-Dependent Fluid Phase Uptake , 2009, Circulation research.

[23]  Michael C. Ostrowski,et al.  Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K , 2009, Circulation research.

[24]  Soo-Ho Choi,et al.  Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein: Toll-Like Receptor 4– and Spleen Tyrosine Kinase–Dependent Activation of NADPH Oxidase 2 , 2009, Circulation research.

[25]  A. Tall,et al.  Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions , 2008, Circulation.

[26]  Dexin Kong,et al.  Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy , 2008, Cancer science.

[27]  M. Febbraio,et al.  Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. , 2008, Cardiovascular research.

[28]  M. Birnbaum,et al.  Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. , 2007, Cell metabolism.

[29]  L. Badimón,et al.  Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. , 2007, Cardiovascular research.

[30]  P. Libby,et al.  Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis , 2007, Proceedings of the National Academy of Sciences.

[31]  W. Zou,et al.  Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption , 2007, The Journal of Cell Biology.

[32]  S. Yamaoka,et al.  Role of the Toll-like Receptor 4/NF-&kgr;B Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[33]  B. Brüne,et al.  Phospholipase A2–Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[34]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[35]  K. Moore,et al.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.

[36]  P. Shah,et al.  Lipopolysaccharide, toll-like receptors, and the immune contribution to atherosclerosis. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[37]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[39]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[40]  D. Schwartz,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[41]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[42]  J. Wilsbacher,et al.  Activation of Syk protein tyrosine kinase through interaction with integrin β cytoplasmic domains , 2001, Current Biology.

[43]  F. Maxfield,et al.  The Uptake and Degradation of Matrix-bound Lipoproteins by Macrophages Require an Intact Actin Cytoskeleton, Rho Family GTPases, and Myosin ATPase Activity* , 2001, The Journal of Biological Chemistry.

[44]  V. Duronio,et al.  Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. , 2001, Journal of lipid research.

[45]  J. Borén,et al.  Role of extracellular retention of low density lipoproteins in atherosclerosis , 2000, Current opinion in lipidology.

[46]  L. Cantley,et al.  SYK Is Upstream of Phosphoinositide 3-Kinase in B Cell Receptor Signaling* , 1999, The Journal of Biological Chemistry.

[47]  F. Maxfield,et al.  Unique Cellular Events Occurring during the Initial Interaction of Macrophages with Matrix-retained or Methylated Aggregated Low Density Lipoprotein (LDL) , 1999, The Journal of Biological Chemistry.

[48]  I. Tabas,et al.  Nonoxidative modifications of lipoproteins in atherogenesis. , 1999, Annual review of nutrition.

[49]  R. Munford,et al.  Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. , 1986, Science.

[50]  Richard G. W. Anderson,et al.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.

[51]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. B. Smith,et al.  The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin. , 1976, Atherosclerosis.

[53]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.